baber/WOPTO huggingface dataset:
Patent NZ-551750-A (NZ)
Title: Feed or feed additive containing an alkaloid
Inventor: ROTH HERMANN
IPC: A23K1/18
Filed: 2005-05-06
Abstract: The disclosure relates to a fodder containing conventional feed substances (which may comprise one or more materials selected from grain or grain products, maize, proteins and essential amino acids, vitamins, mineral additives, like salts, phosphates, lime, enzymes and the like) and fodder additives for producing said fodder, wherein, the fodder additive contains a protopine alkaloid, in particular alpha-allocryptopine, preferably in combination with at least one benzophenanthridine alkaloid in an active quantity as a stimulant and appetite enhancer for commercial animals, and wherein the protopine alkaloid is used to enhance the performance and/or appetite of commercial animals.
Patent NZ-552485-A (NZ)
Title: Humanized anti-cmet antagonists
Inventor: DENNIS MARK S
IPC: C12N15/13
Filed: 2005-08-04
Abstract: Disclosed is an anti-c-met antibody comprising: (a) At least one HVR sequence selected from the group consisting of: (i) HVR-L1 comprising sequence A1-A17, wherein A1-A17 is KSSQSLLYTSSQKNYLA (SEQ ID NO: 1) (ii) HVR-L2 comprising sequence B1-B7, wherein B1-B7 is WASTRES (SEQ ID NO: 2) (iii) HVR-L3 comprising sequence C1-C9, wherein C1-C9 is QQYYAYPWT (SEQ ID NO: 3) (iv) HVR-H1 comprising sequence D1-D10, wherein D1-D10 is GYTFTSYWLH (SEQ ID NO: 4) and (v) HVR-H2 comprising sequence E1-E18, wherein E1-E18 is GMIDPSNSDTRFNPNFKD (SEQ ID NO: 5); and (b) A variant HVR-H3 comprising the sequence T/SYR/SSYVTP/S/ALDY.
Patent NZ-556010-A (NZ)
Title: Metering head for a sower
Inventor: SMITH RONNIE D
IPC: A01C7/04
Filed: 2005-11-29
Abstract: A metering head for a sowing machine having a seed hopper, a furrow opener and a furrow closer, the metering head comprising (a) a housing 60, and (b) a metering disc 62 rotatably disposed within the housing 60, the metering disc 62 having a seed receptacle substantially defining a perimeter of the metering disc 62, wherein the seed receptacle forms a substantially continuous surface around the perimeter of the metering disc 62 to define a channel 70 extending between the perimeter of the metering disc 62 and a portion of the housing 60, the seed receptacle adapted to engage a seed 44 at any random position along the seed receptacle and transport the seed between an inlet port 72 and an outlet port 74.
Patent NZ-561849-A (NZ)
Title: A manual vascular compression device with a rigid convex bottom pad
Inventor: FINKIELSZTEIN SERGIO
IPC: A61B17/00
Filed: 2006-03-29
Abstract: A vascular compression apparatus for applying pressure to tissue in proximity to a puncture site and a blood vessel, comprises a handle 14, a shaft 12 extending generally perpendicularly from the handle 14, and a rigid pad 11 having a top side 19 and a convex bottom side 18, which makes contact with the body surface. The device is configured to allow the user to rock the convex pad 11 proximally and distally.
Patent NZ-569968-A (NZ)
Title: A solid lyophilized taxane composition, a method for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation
Inventor: MOYANO DE ITURRASPIE NORA ADRIANA
IPC: A61K31/337
Filed: 2007-01-19
Abstract: Disclosed is a lyophilized solid composition of taxane, comprising: a) a taxane, b) a tensoactive, c) a lyophilization excipient, and d) an acid, wherein the composition is essentially free from organic solvent and is suitable for the preparation of pharmaceutical formulations for mammals, in particular humans. Also disclosed is the process for preparing the lyophilized taxane composition, a pharmaceutical formulation comprising the lyophilized taxane composition and a kit that contains the lyophilized taxane.
Patent NZ-571282-A (NZ)
Title: Adhesion-promoting compositions comprising a chlorendate group and methods of promoting adhesion between a coating and a substrate
Inventor: RAGUNATHAN KALIAPPA G
IPC: C08G85/00
Filed: 2007-03-29
Abstract: Disclosed is a composition comprising the reaction product of a polymer and a compound comprising a chlorendate group, wherein the polymer comprises a polyol and a cholorinated polyolefin, and wherein the polyol comprises an epoxy polyol, an acrylic polyol, a polyurethane polyol, a polybutadiene polyol and/or a polyether polyol.
Patent NZ-573363-A (NZ)
Title: Compound having affinity for amyloid based on an imidazopyridine-phenyl skeleton
Inventor: TANIFUJI SHIGEYUKI
IPC: C07F7/22
Filed: 2007-05-15
Abstract: Disclosed is a compound of formula (I), having an imidazopyridine-phenyl skeleton and being defined in the complete specification. The disclosed compound is used in the manufacture of a medicament for treating Alzheimer's disease.
Patent NZ-576109-A (NZ)
Title: Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
Inventor: STARK MARCUS
IPC: A61K45/06
Filed: 2007-10-04
Abstract: Disclosed is the use of a sartan e.g. candesartan, eprosartan, irbesartan, losartan, tasosartan, telmisartan, valsartan for the manufacture of a pharmaceutical composition comprising a therapeutically effective amount of sartan for the treatment of chronic kidney disease in cats.
Patent NZ-577082-A (NZ)
Title: Waterborne, radiation-curable coating compositions and related methods
Inventor: PERRINE M
IPC: C08K5/357
Filed: 2007-11-07
Abstract: Disclosed is a waterborne, radiation-curable coating composition comprising: (a1) a water dispersible acrylic polymer (carboxylic acid vinyl polymer for example); (a2) a water dispersible polymer selected from the group consisting of polyurethanes, polyesters, epoxies, polyamides, polyolefins, polyesters, polysiloxanes, oil-modified polymers, copolymers of any thereof, and mixtures of any thereof; (b) a water-insoluble multi-functional ethylenically unsaturated compound (for example trimethylolpropane tri(meth)acrylate); and (c) a neutralizing agent comprising predominantly a monofunctional tertiary amine having a pKa of no more than 9.5 (for example n-ethylmorpholine). Also disclosed is a waterborne, radiation curable coating wherein the composition is viscosity stable for at least 28 days at 120 degrees F when neutralized to a pH of from 7 to 9.
Patent NZ-580998-A (NZ)
Title: Water inlet arrangement comprising a pipe with holes that is surrounded by element with holes and a shield
Inventor: GLOMSET KARSTEN
IPC: A01K63/00
Filed: 2008-05-06
Abstract: Disclosed is a water inlet arrangement when used in a fish tank in aquaculture. The arrangement comprises a pipe (4) to feed water into the tank. The pipe (4) has a plurality of openings. There is a surrounding element (8) and/ or a fixed or adjustable shield (10). The surrounding element surrounds the pipe (4) and has a plurality of openings. The shield (10) surrounds the plurality of lateral openings of the pipe (4) or surrounds the openings of the surrounding element (8).
Patent NZ-585479-A (NZ)
Title: Method of artificially feeding lobster larvae and feeding apparatus
Inventor: TANAKA YUJI
IPC: A01K61/00
Filed: 2008-10-20
Abstract: A method of rearing lobster larvae, in which lobster larvae of the Palinuridae and Scyllaridae families are guided toward jellyfish so that the lobster larvae parasitize the jellyfish and grow on the host jellyfish. Also provided is an apparatus for rearing lobster larvae wherein a symbiotic feeding tank, in which the larvae are reared in the state of being parasitic on the jellyfish, and a jellyfish rearing tank are connected together via a pipe, through which water and the jellyfish are supplied from the jellyfish rearing tank to the symbiotic feeding tank, and the pipe is provided with a switching valve.
Patent NZ-586190-A (NZ)
Title: A utility meter network wherein meters can transmit electrical and other readings to a collector by using other meters as repeaters
Inventor: BORLESKE ANDREW J
IPC: G01D4/00
Filed: 2008-12-24
Abstract: 586190 Disclosed is a method of communication performed by at least one electricity meter (114). A message is received from a battery-powered meter (400) that measures consumption of a commodity other than electricity, the message including an associated meter field containing a destination address. It is then determined whether the associated meter field contains the destination address of the at least one electricity meter (114), thereby establishing an association with the battery powered meter (400). In response to establishing the association, information about measured consumption of the other commodity is received from the associated battery-powered meter (400) and the information is stored. Information about consumption of electricity measured by the at least one electricity meter (114) and the information about consumption of the other commodity received from the associated battery-powered meter are both transmitted to a collector (116) via the wireless network. The information is then transmitted to a remotely located display associated with the at least one electricity meter (114).
Patent NZ-588300-A (NZ)
Title: Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
Inventor: AUDIA JAMES EDMUND
IPC: C07D279/06
Filed: 2009-04-15
Abstract: Disclosed are aminodihydrothiazine compounds of Formula I, salts thereof, and methods for their preparation. Specific examples of compounds of Formula I include: (S)-4-(3-(2-fluoropyridin-3-yl)phenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine, and (S)-4-(4-Fluoro-3-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazine-2-ylamine. The compounds of formula I are potent inhibitors of beta-secretase or beta-site amyloid precursor protein cleaving enzymes. The compounds are useful in the treatment of Alzheimer's disease and other disease and disorders involving amyloid peptide.
Patent NZ-591362-A (NZ)
Title: Multiple-variable dose regimen for treating tnfa-related disorders
Inventor: HOFFMAN REBECA S
IPC: A61P37/00
Filed: 2005-04-11
Abstract: Provided is the use of an isolated human anti-TNF antibody or an antigen-binding portion thereof, in the manufacture of a medicament for treating a skin disorder in which TNF activity is detrimental using a multiple-variable dose regimen, said regimen, when used, comprising administering to a subject in need thereof the medicament comprising at least one induction dose of 80 to 160 mg of the antibody or antigen-binding portion thereof, within an induction phase; and subsequently administering to the subject the medicament comprising at least one treatment dose of the antibody or antigen-binding portion thereof, within a treatment phase, such that treatment occurs, wherein the induction dose is at least twice the amount of the treatment dose. The skin disorder can be psoriasis or hidradenitis suppurativa.
Patent NZ-591766-A (NZ)
Title: Filter assembly for collecting grease from cooking fumes with a stabilising frame to hold the filter pad flat
Inventor: ALEXANDER GLENN DAVID
IPC: B01D39/16
Filed: 2009-09-23
Abstract: 591766 Disclosed is a filter assembly including a filter pad (42a) comprising fibres including natural, synthetic and/or hybrid fibres. A stabilizer frame (44a) formed of a non-metallic material may be imbedded in the filter pad. The stabilizer frame (44a) may be configured to provide support to the filter pad (42a) to maintain the filter pad in a generally flat configuration. The filter pad (42a) is formed from a fibrous mat that is coupled with the stabilizer frame (44a), and each of four edges of the mat are lapped over respective edges of the stabilizer frame (44a).
Patent NZ-592541-A (NZ)
Title: 5-lipoxygenase-activating protein (flap) inhibitors
Inventor: HUTCHINSON JOHN HOWARD
IPC: A61K31/415
Filed: 2006-10-30
Abstract: Disclosed herein are indole compounds of formula (G) wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as 5-lipoxygenase-activating protein (FLAP) inhibitors are and therefore useful in the treatment of inflammation, respiratory disease, cardiovascular disease and obstructive pulmonary disease. Examples of preferred compounds include: · 3-[3-tert-butylsulfanyl-l-(4-pyridin-2-yl-benzyl)-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionamide (Compound 1-1); · 3-[3-tert-butylsulfanyl-l-[4-(6-methoxypyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid ethyl ester (Compound 1-2); · 3-[3-tert-butylsulfanyl-l-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid 6-hydroxy-hexyl ester (Compound 1-3); · 1-[3-tert-butylsulfanyl-l-(4-pyridin-2-yl-benzyl)-5-(pyridin-2-ylmethoxy)1H-indol-2-yl]-2-methyl-propan-2-ol (Compound 1-4); · 3-[3-cyclopropanecarbonyl-5-(pyridin-2-ylmethoxy)-1-(4-thiazol-2-yl-benzyl)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (Compound 2-15); · 3-[3-cyclobutanecarbonyl-5-(pyridin-2-ylmethoxy)-1-( 4-thiazol-2-yl-benzyl)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (Compound 2-16); · 3-[3-tert-butylsulfanyl-1-[ 4-(6-hydroxy-pyridazin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (Compound 2-17); · 3-[3-tert-butylsulfanyl-1-( 4-pyridin-4-yl-benzyl)-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (Compound 2-18); · 3-[3-tert-butylsulfanyl-1-[ 4-( 6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (Compound 2-19).
Patent NZ-595462-A (NZ)
Title: Manual inflator with cylinder connector and status indicator
Inventor: ROGIER STEPHEN J
IPC: B63C9/19
Filed: 2010-04-15
Abstract: 595462 A manual inflator (10), comprising in combination: a body (12) having a boss (14) for receiving a gas cylinder and having an indicator window (48); and a pierce pin assembly (26) reciprocatably mounted within a bore (34) in the body. The pierce pin assembly comprises an actuator (32) of a first color (green) that is in alignment with at least a portion of the indicator window at least when a fully-charged gas cylinder is received in the boss allowing the first color to be visualized through the indicator window and a cap (39) of a second color (red) that is in alignment with at least a portion of the indicator window at least when either a gas cylinder is not received in the boss or a non fully-charged gas cylinder is received in the boss.
Patent NZ-597248-A (NZ)
Title: Solid dispersions containing an apoptosis-promoting agent
Inventor: MILLER JONATHAN MARK
IPC: A61K9/10
Filed: 2010-06-08
Abstract: 597248 Provided is a solid dispersion comprising, in essentially non-crystalline form, a Bcl-2 protein family inhibitor compound of the general formula (I), where R0, X3 and X4 are described in the specification, dispersed in a solid matrix that comprises (a) a water-soluble polymeric carrier and (b) a surfactant. Inhibition of Bcl-2 family proteins promotes apoptosis. A preferred compound is the Bcl-2 protein family inhibitor ABT-263. Further provided is a process for preparing the solid dispersion comprising dissolving the compound, the polymeric carrier and the surfactant in a suitable solvent, and removing the solvent to provide a solid matrix comprising the polymeric carrier and the surfactant and having the compound dispersed in essentially non-crystalline form therein. Also provided is the use of the solid dispersion in the preparation of a medicament for oral administration to a subject with a disease characterized by apoptotic dysfunction and/or overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.
Patent NZ-600083-A (NZ)
Title: Lettuce Line RX 06460500
Inventor: VAN DER LAAN HIERONYMUS J
IPC: A01H5/12
Filed: 2012-05-18
Abstract: Provided is a seed of lettuce line RX 06460500, a sample of seed of said line having been deposited under ATCC Accession Number PTA-10333. Further provided are plant grown from the seeds and offspring of the lettuce line, including F1 hybrid seed and food products produced from the plants.
Patent NZ-602266-A (NZ)
Title: Macrocycles as factor xia inhibitors
Inventor: CORTE JAMES R
IPC: C07D487/08
Filed: 2011-02-10
Abstract: 602266 Disclosed are compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. Also disclosed are pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using them. Examples of compound of formula (I) are: (9S,14S)-14-[(E)-3-(5-Chloro-2-tetrazol-1-yl-phenyl)-acryloylamino]-5-(2-methoxyethoxycarbonylamino)-8,16-diaza-tricyclo[13.3.1.02,7]nonadeca-1(19),2,4,6,15,17-hexaene-9-carboxylic acid ethyl ester, bis-trifluoroacetic acid salt; (9R,14S)-14-[(E)-3-(5-Chloro-2-tetrazol-1-yl-phenyl)-acryloylamino]-5-methoxycarbonylamino-8,17-diaza-tricyclo[13.3.1.02,7]nonadeca-1(19),2(7),3,5,15,17-hexaene-9-carboxylic acid ethyl ester 2-TFA salt and 9R,14S)-14-[(E)-3-(5-Chloro-2-tetrazol-1-yl-phenyl)-acryloylamino]-5-methoxycarbonylamino-8,16-diaza-tricyclo[13.3.1.02,7]nonadeca-1(19),2(7),3,5,15,17-hexaene-9-carboxylic acid ethyl ester.
Patent NZ-603939-A (NZ)
Title: Conjugated blood coagulation factor viii
Inventor: HENRY WILLIAM
IPC: A61K38/37
Filed: 2011-04-28
Abstract: 603939 Discloses a Factor VIII-polyethylene glycol (PEG) conjugate, wherein one of more polyethylene glycol groups are conjugated to FVIII by a linker group bridging the sulphur atoms of two cysteine residues that formed a disulphide bond in FVIII.
Patent NZ-605982-A (NZ)
Title: Compositions containing flavones and anthelmintics
Inventor: KERBOEUF DOMINIQUE
IPC: C07D311/30
Filed: 2011-06-10
Abstract: Disclosed is a composition comprising a flavone compound of formula I, and an anthelmintic selected from the group comprising: levamisole, macrocyclic lactones selected from the group comprising avermectins or from the group comprising milbemycins, benzimidazole derivatives selected from albendazole, thiabenzole, mebendazole, fenbendazole, oxfendazole, febantal, and oxibendazole, that increases the bioavailable amount of the anthelmintic to treat parasitosis for example nematodes. Also disclosed is the use of the composition for preparing a medicinal product that is able to increase the bioavailability of anthelmintics in nematodes, for the treatment or prevention in a vertebrate of a parasitosis due to a nematode belonging to the Helminths phylum of the Metazoa.
Patent NZ-610853-A (NZ)
Title: Phenylketone carboxylate compounds and pharmaceutical uses thereof
Inventor: ABBOTT SHAUN
IPC: C07C323/62
Filed: 2011-10-26
Abstract: Disclosed are phenylketone carboxylate compounds of formula I where the substituents are as defined herein such as (RS)-2[4-octanoylphenoxy]decanoate. Also disclosed are their methods of synthesis and the use of such compounds in the treatment of blood disorders, inflammation-related diseases, renal disorders and fibrosis related organ dysfunction.
Patent NZ-618276-A (NZ)
Title: Systems and methods for energy management and device automation system
Inventor: FAKOS JIM
IPC: H02J13/00
Filed: 2012-02-02
Abstract: An integrated energy management and device automation system for managing a premises electrical system having a plurality of electrical circuits is disclosed. The energy management and device automation system comprises a central controller (1). The central controller (1) is configured to receive, over the premises electrical system, energy usage data from a plurality of modules and module originated notifications that a module has been connected to the premises electrical system. The central controller (1) is configured to receive and send, over the premises electrical system, messages for device automation and control from a plurality of modules. The energy management system additionally comprises a plurality of modules. Each module comprises a processor, a powerline interface operatively connected to the processor and to one of the plurality of electrical circuits and a sensor operatively connected to the electrical circuit so that the sensor can sense at least one of current and voltage. Each module is configured to collect data relating to energy usage using the sensor and to transmit the data to the central controller (1). The central controller (1) uses energy usage data to identify, profile and analysis connected devices and their usage. The central controller (1) is additionally configured to use standard device profiles with known energy usage patterns to identify the identifiable electrical device when the identifiable electrical device is connected to the one of the plurality of electrical circuits.
Patent NZ-618286-A (NZ)
Title: Nitrogen containing compounds suitable for preventing or treating bacterial infections
Inventor: BHAGWAT SACHIN
IPC: C07D471/08
Filed: 2012-09-11
Abstract: Disclosed is trans-7-oxo-6-(sulphoxy)-1,6-diazabicyclo[3,2,1]octane-2-carbonitrile and its salts of formula (I), wherein M is a cation selected from hydrogen, sodium, or potassium. Also disclosed is the use of compounds of formula (I) for treating or preventing bacterial infections, particularly bacterial infections caused by bacterial producing beta-lactamase enzymes.
Patent NZ-625977-A (NZ)
Title: Methods for providing sialylated oligosaccharides
Inventor: SALLOMONS ERIK
IPC: A23L33/00
Filed: 2012-12-06
Abstract: The disclosure relates to a method for providing a composition comprising sialic acid containing oligosaccharides, comprising the steps of: a) providing a source of non-digestible galactooligosaccharides (GOS) containing at least two terminally bonded beta-linked galactose residues; b) providing a sialic acid donor having (alpha2-3)-sialylated O-glycans; c) contacting said GOS with said sialic acid donor in the presence of an enzyme having trans-sialidase activity in an enzyme reaction mixture; and d) obtaining from said enzyme reaction mixture a fraction comprising at least 5 percent by weight of disialylated galactooligosaccharides (di-Sia-GOS) based on the dry matter.
Patent NZ-629040-A (NZ)
Title: Fiber optic connector, fiber optic connector and cable assembly, and methods for manufacturing
Inventor: OTT MICHAEL JAMES
IPC: G02B6/38
Filed: 2013-02-20
Abstract: Disclosed is a fiber optic assembly including a ferrule assembly with a ferrule and a stub fiber. The assembly also includes a front hub portion mounted on the ferrule and a fiber optic cable with a cable fiber that is fusion spliced to the stub fiber at a splice location. The front hub portion has a first construction including a first material, and the front hub portion includes a front flange that includes the first material. A rear hub portion covers the splice location and has a second construction including at least a second material that is softer than the first material. The rear hub portion includes an outer hub shell that mounts behind the front flange and has a pre-molded polymeric construction with a fixed size and shape. The outer hub shell also has a fixed size interior cavity that receives the second material such that the interior cavity is filled with the second material and the second material encapsulates the splice location within the outer hub shell. The outer hub shell remains a permanent part of the hub after the interior cavity has been filled with the second material.